Central Pacific Bank - Trust Division’s Edwards Lifesciences EW Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$822K	Hold	9,088	–	–	0.08%	230
2026 Q1	$728K	Hold	9,088	–	–	0.09%	224
2025 Q4	$775K	Buy	+9,088	New	+$746K	0.1%	226
2024 Q4	–	Sell	-7,736	Closed	-$510K	–	898
2024 Q3	$510K	Sell	7,736 -4,382	-36%	-$318K	0.06%	275
2024 Q2	$1.12M	Sell	12,118 -145	-1%	-$12.8K	0.13%	163
2024 Q1	$1.16M	Buy	+12,263	New	+$1.03M	0.14%	162

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Central Pacific Bank - Trust Division's EW Position: Q2 2026 in Review

Central Pacific Bank - Trust Division held its Edwards Lifesciences (EW) position steady in Q2 2026 at 9,088 shares worth $822K. The position accounts for 0.08% of the portfolio, ranked #230.

Central Pacific Bank - Trust Division first reported a position in EW in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.16M in Q1 2024. 305 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Central Pacific Bank - Trust Division held 9,088 shares of Edwards Lifesciences worth $822K as of Q2 2026.
Central Pacific Bank - Trust Division left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.08% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #230 holding.
Central Pacific Bank - Trust Division first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 6 quarters since.
Central Pacific Bank - Trust Division's Edwards Lifesciences position peaked at $1.16M in Q1 2024.
305 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.